Impact of disease burden on long-term outcome of 19-28z CAR modified T cells in adult patients with relapsed B-ALL.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of disease burden on long-term outcome of 19-28z CAR modified T cells in adult patients with relapsed B-ALL.

Published:2016-05-20 Issue:15_suppl Volume:34 Page:7003-7003
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Park Jae Hong¹,Riviere Isabelle¹,Wang Xiuyan¹,Purdon Terence¹,Sadelain Michel¹,Brentjens Renier J.¹

Affiliation:

1. Memorial Sloan Kettering Cancer Center, New York, NY;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.7003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cell therapy for hematological malignancies: History, status and promise;Heliyon;2023-11

2. Chimeric antigen receptor T cells and management of toxicities: implications of biomarkers;Cancer Biomarkers;2022

3. Recent advances in the prevention and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy;European Journal of Inflammation;2022-01

4. Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany;Gene Therapy;2021-03-22

5. Enhancing CAR T cell efficacy: the next step toward a clinical revolution?;Expert Review of Hematology;2020-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP